可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: A critical review of the evidence[J]. JAMA, 2003, 290(7):932-940.
[2]Tasneem Z, Naqvi M, Syed S, et al. Gender difference in the link between depression and cardiovascular disease[J]. Psychosomatic Med, 2005, 67(1):16-18.
[3]Rahman S, Matthew MB, Aseem V. C-reactive protein and vulnerability to mental stress-induced myocardial ischemia[J]. Mol Med, 2006, 12(11):269-274.
[4]Honig A, Maes M. Psychoimmunology as a common pathogenetic pathway in myocardial infarction, depression and cardiac death[J]. Behavioural Med, 2000, 13(6):660-664.
[5]孙宁玲. 抑郁症与冠心病[J]. 中华内科杂志, 2002, 41(11):785-786.
[6] 黄颐,孙学礼,付华. 心血管疾病中的心理问题[J]. 国外医学·精神病学册, 2004, 31(1):10-12.
[7]Herbert E, Tueth M, Sheps D, et al. Depression and cardiovascular disease[J]. Behavioural Med, 2003, 16(2):221-225.
[8]Miller GE, Stetler CA, Carney RM, et al. Clinical depression and inflammatory risk markers for coronary heart disease[J]. Am J Cardiol, 2002, 90(12):1279-1283.
[9]国际心脏病学会和协会(IFSC)及世界卫生组织(WHO)临床命名标准化联合专题组. 缺血性心脏病命名及诊断标准[J]. 中华心血管病杂志, 1981, 9(1):75-76.
[10]中华医学会精神分会. 中国精神障碍分类与诊断标准[M]. 第3版. 济南: 山东科学技术出版社, 2001:87-89,98-100.
[11]杨菊贤. 心理行为因素与心血管疾病的发生发展[J]. 心血管康复医学杂志, 2003, 12(7):493-496.
[12]Danner M, Kasl SV, Abramson JL, et al. Association between depression and elevated C-reactive protein[J]. Psychosom Med, 2003, 65(3):347-356.
[13]陈银娣,周天锌. 老年冠心病病人焦虑、抑郁症状的调查[J]. 上海精神医学, 2002, 12(1):17.
[14]Clouse RE, Lustman PJ, Freedland KE, et al. Depression and coronary heart disease in women with diabetes[J]. Psychosom Med, 2003, 65(3):376-383.
[15]Barefoot JC, Helm S, Mark DB, et al. Depression and long term mortality risk in patients with coronary artery disease[J]. Am J Cardiol, 1996, 78(6):613-617.
[16]Carney RM, Freedland KE, Stein PK, et al. Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease[J]. J Psychosom Res, 2007, 62(4):463-467.
[17]Davies SJ, Jackson PR, Potokar J, et al. Treatment of anxiety and depressive disorders in patients with cardiovascular disease[J]. BMJ, 2004, 328(7445):939-943.
[18]Maes M, Bosmans E, De jongh R, et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression[J]. Cytokine, 1997, 9(11):853-858.
[19]Ross R. Atherosclerosis-an inflammatory disease[J]. N Eng J Med, 1999, 340(4):115-126.
[20]Ramadan MM, Kodama M, Mitsuma W, et al. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease[J]. Am J Cardiol, 2006, 98(7):915-917.
[21]Danesh J, Kaptoge S, Mann AG, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review[J]. Plos Med, 2008, 5(4):e78.
[22]王东林,林文娟. 细胞因子与抑郁症发病机制研究进展[J]. 中国神经精神疾病杂志, 2007, 33(9):572-574.